6/25/2015 | IG | Moody’s cuts Zimmer to Baa3
|
6/24/2015 | IG | S&P downgrades Zimmer
|
3/31/2015 | IG | Market Commentary: Morning Commentary: Deutsche Bank notes improve; Zimmer tightens in secondary trading
|
3/12/2015 | IG | Market Commentary: Morning Commentary: Zimmer short-dated notes tighten; Barclays flat; credit spreads stable
|
3/11/2015 | IG | New Issue: Zimmer details $7.65 billion seven-part sale of senior notes
|
3/10/2015 | EMHYMUPFPV | Market Commentary: Zimmer sells $7.35 billion; ING, FMS also price; Bank of America, JPMorgan weaker
|
3/10/2015 | IG | Market Commentary: Zimmer sells $7.35 billion; ING, FMS also price; Bank of America, JPMorgan weaker
|
3/10/2015 | IG | New Issue: Zimmer prices $7.65 billion of senior notes in seven tranches
|
3/10/2015 | BKIG | Moody's rates Zimmer notes Baa3
|
3/10/2015 | IG | S&P gives A- to Zimmer notes
|
3/10/2015 | IG | Zimmer talks benchmark seven-part notes offering for Tuesday pricing
|
3/10/2015 | IG | Zimmer Holdings intends to sell senior notes in seven tranches
|
6/4/2014 | BK | Zimmer details bridge loan, revolver, term loan for Biomet buyout
|
5/23/2014 | IG | S&P rates Zimmer loans A-, BBB
|
4/30/2014 | BKIG | Zimmer gets commitment from Credit Suisse for $12.01 billion loans
|
4/24/2014 | IG | Moody's might drop Zimmer notes
|
4/24/2014 | BKIG | Zimmer gets 364-day bridge loan for $13.35 billion Biomet acquisition
|
4/24/2014 | BKIG | S&P: Zimmer on watch due to proposed acquisition
|
11/6/2012 | CVIGPF | Zimmer files automatic shelf for debt securities, preferreds, stock
|
5/16/2012 | BKIG | S&P rates Zimmer loan A-
|
5/15/2012 | BK | Zimmer and subsidiaries get $1.35 billion credit facility due 2017
|
11/7/2011 | BK | Zimmer to pay down $350 million of revolver with note proceeds
|
11/7/2011 | IG | New Issue: Zimmer prices $550 million 1.4% notes due 2014, 3.375% notes due 2021
|
11/7/2011 | IG | S&P rates Zimmer notes A-
|
11/7/2011 | IG | Market Commentary: Canadian Railway, Zimmer bring deals; Jefferies bucks sector weakness; telecom bonds widen
|
11/16/2009 | IG | Market Commentary: Westpac, Progress, BBVA, Kellogg among issuers; new deals trade briskly, secondary volume light
|
11/13/2009 | IG | Market Commentary: Lockheed Martin, Thermo Fisher sell bonds; Universal eyes split-rated sale; new deals flat
|
11/12/2009 | CVIG | Zimmer files automatic shelf registration for debt, preferreds, stock
|
11/12/2009 | IG | New Issue: Zimmer Holdings prices $1 billion of notes in 10-, 30-year tranches
|
11/12/2009 | IG | S&P rates Zimmer notes A-
|
11/12/2009 | IG | Moody's rates Zimmer notes Baa1
|
11/12/2009 | IG | Market Commentary: Quest Diagnostics, Zimmer, Raytheon, Waste Management among day's sales; spreads ease
|
12/19/2007 | IG | S&P rates Zimmer loans A-
|
9/17/2007 | SP | New Issue: JPMorgan prices $1 million 10.1% reverse exchangeables linked to Zimmer
|
8/29/2007 | SS | Market Commentary: Alltel climbs as shareholders OK LBO; Zimmer to buy Orthosoft; Whole Foods up after reaping Wild Oats
|
10/10/2006 | SP | Morgan Stanley plans issue of 0% notes linked to 97 stocks, S&P 500 Total Return
|
8/16/2006 | BT | RBC Capital Markets orthopedic report: hip market up at $1.1 billion, growth rates slow
|
8/11/2006 | BT | Tutogen says Zimmer's indication of interest inadequate
|
7/28/2006 | BT | JMP reiterates Celgene at market outperform
|
7/28/2006 | BT | Market Commentary: Genitope crashes; Biomet firms; Dynavax tumbles; Nymox gains; Napo debut in London next week
|
7/27/2006 | BT | Zimmer rated at outperform by RBC
|
7/24/2006 | BT | Zimmer at outperform by RBC
|
7/6/2006 | BT | Zimmer to sell ceramic hip replacements
|
6/21/2006 | BT | FDA approves IND for living tissue graft product from ISTO, Zimmer Holdings
|
4/28/2006 | BT | JMP upgrades Zimmer Holdings to market perform
|
4/27/2006 | BT | Zimmer still at market underperform by JMP
|
3/22/2006 | BT | Zimmer's Gender Solutions offers knee replacement designed for women
|
3/13/2006 | BT | Tutogen Medical contacted by Zimmer Holdings to discuss strategic transactions
|
1/31/2006 | BT | Zimmer maintained at market underperform by JMP
|
1/6/2006 | BT | JMP: St. Jude, Medtronic best bets in medical device stocks; still wary of orthopedics
|
12/15/2005 | BT | Zimmer Holdings to repurchase $1 billion in common stock
|
12/14/2005 | BT | Zimmer's Trilogy AB ceramic hip replacement system gets approvable letter from FDA
|
10/27/2005 | BT | JMP maintains Zimmer at underperform
|
9/27/2005 | BT | Zimmer initiated by JMP at market underperform
|
5/20/2003 | BK | Moody's puts Zimmer on review
|